CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY-Reference-Cited by-同舟云学术

CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY

Published:2015-11 Issue:11 Volume:35 Page:2252-2259
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Muakkassa Nora W.,Chin Adam T.,de Carlo Talisa,Klein Kendra A.,Baumal Caroline R.,Witkin Andre J.,Duker Jay S.,Waheed Nadia K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference22 articles.

2. . Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.;Rouvas;Retina,2011

3. Ocular histoplasmosis syndrome.;Diaz;Surv Ophthalmol,2015

4. . Myopic choroidal neovascularization: current concepts and update on clinical management.;Wong;Br J Ophthalmol,2015

5. . Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.;Chan;Am J Ophthalmol,2003

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Impact of Diabetic Retinopathy on Response to Anti-VEGF Treatment in Neovascular AMD;Investigative Ophthalmology & Visual Science;2024-08-02

2. Optical coherence tomography angiography in the diagnosis of ocular disease;Clinical and Experimental Optometry;2024-03-07

3. Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy;Eye and Vision;2024-02-07

4. Features of optical coherence tomography angiography in age-related macular degeneration with residual fluid after three loading doses of aflibercept;Eye and Vision;2024-02-01

5. The Current Role of OCTA in the Management of Pathological Choroidal Neovascularization with Anti-VEGF Therapy;Optical Coherence Tomography Angiography for Choroidal and Vitreoretinal Disorders – Part 2;2023-12-27